UPLC–QTOF/MS-based metabolomic profiling of Lespedeza species for marker selection and monoamine oxidase inhibitory activity
Year: 2026
Type: article
Abstract: Monoamine oxidases (MAO)-A and MAO-B are key enzymes involved in the regulation of monoamine neurotransmitters and are closely associated with various neuropsychiatric and neurodegenerative disorders. In this study, the MAO-A and MAO-B inhibitory activities of methanol extracts from Korean native Lespedeza species were compared and related to metabolite profiles using ultra-performance liquid chromatography–quadrupole time-of-flight mass spectrometry (UPLC–QTOF/MS)-based metabolomics combined with in silico prediction of central nervous system distribution. Among the tested species ( L. maximowiczii , L. thunbergii , L. tomentosa , and L. cyrtobotrya ), L. cyrtobotrya exhibited the strongest inhibitory activity, with the stem extract showing the most pronounced effect (MAO-A 80.33% and MAO-B 91.91% inhibition at 20 µg/mL). Untargeted metabolomic analysis tentatively identified 65 secondary metabolites, and multivariate statistical analyses including principal component analysis (PCA) and orthogonal partial least squares discriminant analysis (OPLS-DA) clearly discriminated L. cyrtobotrya from the other species and further separated its leaf and stem extracts. Marker selection based on the OPLS-DA S-plot and subsequent box plot analysis ( p < 0.05) indicated that non-prenylated flavonoids were enriched in the leaf, whereas prenylated flavonoids such as diplacone, sanggenol A, and xanthoangelol were relatively enriched in the stem. SwissADME and pkCSM-based in silico predictions indicated diverse physicochemical and central nervous system distribution properties among the selected metabolites (log P − 0.24–5.30; log BB − 2.41–−0.57; log PS − 5.24–−1.95), with stem-enriched prenylated flavonoids showing relatively higher lipophilicity. Overall, this integrated bioactivity-metabolomics approach identifies L. cyrtobotrya stem as a promising source of MAO-modulating metabolites, including diplacone and sanggenol A, whose moderate MAO inhibitory activities were directly confirmed in the present study.
Source: Applied Biological Chemistry
Language: English
Subfield: Plant Science
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $1,690
OpenAlex ID: W7234196401
